[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1975

FDA Drug Bulletin—Radiation

Author Affiliations

Oakland, Calif

Arch Dermatol. 1975;111(7):925-926. doi:10.1001/archderm.1975.01630190115020
Abstract

To the Editor.—  In June 1974, the FDA Drug Bulletin published a short article on the delayed effects of head and neck radiation.1 They quoted the studies in Israel and in New York on neoplastic development in persons having had x-ray epilation for tinea capitis.2,3 On this basis, they concluded with the following paragraph, Today, with specific or alternative methods of treatment for benign disease, the indications for x-ray therapy are rare. With the knowledge that relatively low doses of radiation can be responsible for the development of benign and malignant tumors, caution in the use of ionizing radiation for benign disease is well justified.In response, on July 28, 1974, I wrote a letter to Caspar Weinberger, Secretary of the US Department of Health, Education, and Welfare, which said in part,. . . this slanted article could make the defense of medicolegal actions regarding the use of radiation therapy

First Page Preview View Large
First page PDF preview
First page PDF preview
×